These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12599336

  • 1. [Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
    Störh M.
    Nervenarzt; 2002 Dec; 73(12):1207; author reply 1207. PubMed ID: 12599336
    [No Abstract] [Full Text] [Related]

  • 2. Methylprednisolone pulse therapy for severe immune thrombocytopenia associated with infectious mononucleosis.
    Takahashi T, Hamasaka N, Harada S, Sugawara N, Yoshimoto M.
    Am J Hematol; 2007 May; 82(5):416-7. PubMed ID: 17160996
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)].
    Kommerell G.
    Klin Monbl Augenheilkd; 1994 Sep; 205(3):126-7. PubMed ID: 7996815
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [2012: Update on diagnosis and treatment of multiple sclerosis].
    Havla J, Kümpfel T, Hohlfeld R.
    Dtsch Med Wochenschr; 2012 Apr; 137(17):894-9. PubMed ID: 22492476
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
    Lyons PR, Newman PK, Saunders M.
    J Neurol Neurosurg Psychiatry; 1988 Feb; 51(2):285-7. PubMed ID: 3346696
    [Abstract] [Full Text] [Related]

  • 9. [Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].
    Kling A, Dahlqvist R.
    Lakartidningen; 1988 Feb; 104(3):128-30. PubMed ID: 17302117
    [No Abstract] [Full Text] [Related]

  • 10. [Cortisol suppression in corticoid therapy. Comments on the contribution by R. Voltz and R. Hohlfeld. Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Haupts M, Schlüter T, Gehlen W.
    Nervenarzt; 1993 Jun; 64(6):413. PubMed ID: 8332236
    [No Abstract] [Full Text] [Related]

  • 11. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D.
    J Neurol Sci; 2004 Aug 15; 223(1):73-9. PubMed ID: 15261565
    [Abstract] [Full Text] [Related]

  • 12. [Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis].
    Weilbach FX, Toyka KV, Hartung HP.
    Nervenarzt; 1995 Aug 15; 66(8):643-7. PubMed ID: 7566279
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy of MS symptoms. Here also are guidelines necessary].
    Henze T, Toyka KV.
    Nervenarzt; 2004 Aug 15; 75 Suppl 1():S1. PubMed ID: 15480525
    [No Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive therapy in multiple sclerosis].
    Vinychuk SM, Mialovyts'ka OA, Koliendo OO.
    Lik Sprava; 2003 Aug 15; (7):76-81. PubMed ID: 14723143
    [Abstract] [Full Text] [Related]

  • 15. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    Tremlett H.
    Lancet; 1997 Jun 07; 349(9066):1696-7. PubMed ID: 9186400
    [No Abstract] [Full Text] [Related]

  • 16. Interferon-beta therapy for MS: the dilemma of having choices.
    Khan O.
    J Neurol Sci; 2004 Jul 15; 222(1-2):1. PubMed ID: 15240187
    [No Abstract] [Full Text] [Related]

  • 17. High-dose methylprednisolone in acute spinal cord injuries: proceed with caution.
    Pandya KA, Weant KA, Cook AM.
    Orthopedics; 2010 May 15; 33(5):327-31. PubMed ID: 20507035
    [No Abstract] [Full Text] [Related]

  • 18. Early aggressive treatment strategy against myasthenia gravis.
    Nagane Y, Suzuki S, Suzuki N, Utsugisawa K.
    Eur Neurol; 2011 May 15; 65(1):16-22. PubMed ID: 21116111
    [Abstract] [Full Text] [Related]

  • 19. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
    Uttner I, Müller S, Zinser C, Maier M, Süssmuth S, Claus A, Ostermann B, Elitok E, Ecker D, Brettschneider J, Gold R, Tumani H.
    Neurology; 2005 Jun 14; 64(11):1971-3. PubMed ID: 15955958
    [Abstract] [Full Text] [Related]

  • 20. Natalizumab: bound to rebound?
    Schiess N, Calabresi PA.
    Neurology; 2009 Feb 03; 72(5):392-3. PubMed ID: 19188569
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.